MedTrace Logo

Clinical Value of the MRI Combined With SCC-Ag for the Diagnosis of HSIL (CIN 2/3)

NCT05487209 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 186

Last updated 2023-07-06

No results posted yet for this study

Summary

The study aimed to identify the clinical value of Magnetic Resonance Imaging examination (MRI)combined with serum squamous cells carcinoma antigen (SCC-Ag) in women with high-grade squamous intraepithelial lesion (cervical intraepithelial neoplasia grades 2-3 (CIN 2-3)).

Conditions

  • Magnetic Resonance Imaging Examination

Interventions

DIAGNOSTIC_TEST

MRI,SCC-Ag

Magnetic Resonance Imaging examination,serum squamous cells carcinoma antigen

Sponsors & Collaborators

  • Second Affiliated Hospital of Wenzhou Medical University

    lead OTHER

Principal Investigators

  • Zhao · The 2nd Affiliated Hospital and Yuying Children's Hospital of WMU

Eligibility

Min Age
26 Years
Max Age
82 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2022-12-01
Completion
2022-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05487209 on ClinicalTrials.gov